-
Published 4/1/2026
Jeng PJ, Jalali A, Yeung K, Luce C, Lu T, Lee AK, LaBelle CT, Bradley KA, Murphy SM. The cost of implementing and sustaining the Massachusetts model. Am J Manag Care. 2026 Apr 01; 32(4):e110-e117. PMID: 42044398.
-
Published 2/15/2025
Matson TE, Lee AK, Miech EJ, Wartko PD, Phillps RC, Shea M, Altschuler A, Campbell ANC, Labelle CT, Arnsten JH, Braciszewski JM, Glass JE, Horigian VE, Murphy MT, Zare-Mehrjerdi M, Bradley KA. The difference-making role of staff support in implementing nurse care management for opioid use disorder treatment: A configurational analysis. J Subst Use Addict Treat. 2025 May; 172:209642. PMID: 39961581.
-
Published 1/23/2025
Carney BL, Loukas V, LaBelle CT. Harm Reduction Is Nursing Practice. Am J Nurs. 2025 Feb 01; 125(2):8. PMID: 39844212.
-
Published 7/23/2024
Jawa R, Blakemore S, Murray S, Ventura AS, Hristova T, Wilder A, Shang M, Johnson T, LaBelle C. Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine. J Addict Med. 2024 Nov-Dec 01; 18(6):723-726. PMID: 39051898.
-
Published 2/20/2024
Jawa R, Murray S, Blakemore S, Ventura AS, Hristova T, Wilder A, Shang M, LaBelle C. Xylazine and Adulterants in the Evolving Drug Supply: Urgent Call for Responsive Education Models. Subst Use Addctn J. 2024 Apr; 45(2):168-175. PMID: 38375666.